LFCR
Price
$6.85
Change
+$0.10 (+1.48%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
176.87M
82 days until earnings call
LNTH
Price
$81.58
Change
+$1.25 (+1.56%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
4.27B
55 days until earnings call
Interact to see
Advertisement

LFCR vs LNTH

Header iconLFCR vs LNTH Comparison
Open Charts LFCR vs LNTHBanner chart's image
Lifecore Biomedical
Price$6.85
Change+$0.10 (+1.48%)
Volume$6.63K
Capitalization176.87M
Lantheus Holdings
Price$81.58
Change+$1.25 (+1.56%)
Volume$16.33K
Capitalization4.27B
LFCR vs LNTH Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. LNTH commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and LNTH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (LFCR: $6.76 vs. LNTH: $80.37)
Brand notoriety: LFCR and LNTH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 41% vs. LNTH: 123%
Market capitalization -- LFCR: $176.87M vs. LNTH: $4.27B
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. LNTH’s [@Pharmaceuticals: Other] market capitalization is $4.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileLNTH’s FA Score has 2 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • LNTH’s FA Score: 2 green, 3 red.
According to our system of comparison, LNTH is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while LNTH’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 2 bearish.
  • LNTH’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than LNTH.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -1.24% price change this week, while LNTH (@Pharmaceuticals: Other) price change was +6.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +79.53%. For the same industry, the average monthly price growth was +16.37%, and the average quarterly price growth was +68.04%.

Reported Earning Dates

LFCR is expected to report earnings on Aug 27, 2025.

LNTH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+79.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: -8.950 vs. LNTH (-10.161). LNTH has higher annual earnings (EBITDA): 491M vs. LFCR (-22.64M). LNTH has more cash in the bank: 714M vs. LFCR (4.22M). LFCR has less debt than LNTH: LFCR (157M) vs LNTH (617M). LNTH has higher revenues than LFCR: LNTH (1.3B) vs LFCR (188M).
LFCRLNTHLFCR / LNTH
Capitalization177M4.27B4%
EBITDA-22.64M491M-5%
Gain YTD-8.950-10.16188%
P/E RatioN/A12.93-
Revenue188M1.3B15%
Total Cash4.22M714M1%
Total Debt157M617M25%
FUNDAMENTALS RATINGS
LFCR vs LNTH: Fundamental Ratings
LFCR
LNTH
OUTLOOK RATING
1..100
783
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
9940
PRICE GROWTH RATING
1..100
5086
P/E GROWTH RATING
1..100
411
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (62) in the Medical Specialties industry is in the same range as LFCR (92) in the Industrial Specialties industry. This means that LNTH’s stock grew similarly to LFCR’s over the last 12 months.

LNTH's Profit vs Risk Rating (30) in the Medical Specialties industry is significantly better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that LNTH’s stock grew significantly faster than LFCR’s over the last 12 months.

LNTH's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for LFCR (99) in the Industrial Specialties industry. This means that LNTH’s stock grew somewhat faster than LFCR’s over the last 12 months.

LFCR's Price Growth Rating (50) in the Industrial Specialties industry is somewhat better than the same rating for LNTH (86) in the Medical Specialties industry. This means that LFCR’s stock grew somewhat faster than LNTH’s over the last 12 months.

LFCR's P/E Growth Rating (4) in the Industrial Specialties industry is in the same range as LNTH (11) in the Medical Specialties industry. This means that LFCR’s stock grew similarly to LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRLNTH
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 16 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MZZ9.72N/A
N/A
ProShares UltraShort MidCap400
FXF108.10-0.23
-0.21%
Invesco CurrencyShares® Swiss Franc
BXMX13.57-0.05
-0.37%
NUVEEN S&P BUY-WRITE Income FUND
FFA19.70-0.10
-0.51%
First Trust Enhanced Equity Income Fund
NURE29.85-0.20
-0.66%
Nuveen Short-Term REIT ETF

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.67%
SHPH - LFCR
31%
Poorly correlated
-7.41%
ALKS - LFCR
28%
Poorly correlated
-1.73%
OGI - LFCR
27%
Poorly correlated
-2.24%
AMRX - LFCR
27%
Poorly correlated
-0.55%
TLRY - LFCR
27%
Poorly correlated
-5.40%
More

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+0.93%
ACET - LNTH
32%
Poorly correlated
-5.25%
SNDL - LNTH
26%
Poorly correlated
N/A
LFCR - LNTH
24%
Poorly correlated
-1.67%
ORGO - LNTH
24%
Poorly correlated
+0.87%
ACB - LNTH
24%
Poorly correlated
-2.93%
More